AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+3.76%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.81B
AUM Growth
+$3.81B
(+22%)
Cap. Flow
+$500M
Cap. Flow
% of AUM
13.12%
Top 10 Holdings %
Top 10 Hldgs %
27.74%
Holding
148
New
36
Increased
35
Reduced
28
Closed
31
Top Buys
| 1 |
Iovance Biotherapeutics
IOVA
|
$87.7M |
| 2 |
Burlington
BURL
|
$82.6M |
| 3 |
Travere Therapeutics
TVTX
|
$49.5M |
| 4 |
Target Hospitality
TH
|
$46.3M |
| 5 |
lululemon athletica
LULU
|
$44.8M |
Top Sells
| 1 |
TJX Companies
TJX
|
$74.6M |
| 2 |
Lantheus
LNTH
|
$57.7M |
| 3 |
Advance Auto Parts
AAP
|
$50.2M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$48.5M |
| 5 |
BioNTech
BNTX
|
$47.5M |
Sector Composition
| 1 | Healthcare | 64.18% |
| 2 | Consumer Discretionary | 14.71% |
| 3 | Consumer Staples | 11.64% |
| 4 | Communication Services | 3.07% |
| 5 | Industrials | 2.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Avalo Therapeutics
AVTX
$122M
| $128M | 2.29% | 39,100,000 +6,465,715 | +20% | +$21.1M |
|
2
Biogen
BIIB
$19.4B
| $127M | 2.28% | 368,000 +80,000 | +28% | +$27.7M |
|
3
Vertex Pharmaceuticals
VRTX
$100B
| $121M | 2.17% | 600,000 +208,000 | +53% | +$41.9M |
|
4
Bristol-Myers Squibb
BMY
$96B
| $112M | 2.01% | 1,678,000 +178,000 | +12% | +$11.9M |
|
|
MRTX
5
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $107M | 1.91% | 660,000 +124,000 | +23% | +$20M |
|
6
Supernus Pharmaceuticals
SUPN
$2.53B
| $102M | 1.83% | 3,324,000 -88,000 | -3% | -$2.71M |
|
7
Alkermes
ALKS
$4.78B
| $95.6M | 1.71% | 3,900,000 +376,000 | +11% | +$9.22M |
|
8
PTC Therapeutics
PTCT
$3.92B
| $88.4M | 1.58% | 2,092,000 +696,000 | +50% | +$29.4M |
|
9
Enanta Pharmaceuticals
ENTA
$180M
| $88M | 1.58% | 2,000,000 +352,000 | +21% | +$15.5M |
|
|
10
Iovance Biotherapeutics
IOVA
$807M
| $87.7M | 1.57% | +3,372,000 | New | +$87.7M |
|
11
Regeneron Pharmaceuticals
REGN
$61.5B
| $87.1M | 1.56% | 156,000 -19,000 | -11% | -$10.6M |
|
12
Amazon
AMZN
$2.44T
| $86M | 1.54% | 25,000 | – | – |
|
|
13
Travere Therapeutics
TVTX
$1.56B
| $83.9M | 1.5% | 5,748,000 +3,392,000 | +144% | +$49.5M |
|
|
14
Burlington
BURL
$18.3B
| $82.6M | 1.48% | +256,462 | New | +$82.6M |
|
15
Incyte
INCY
$16.5B
| $81.1M | 1.45% | 964,000 -68,000 | -7% | -$5.72M |
|
16
Zymeworks
ZYME
$1.12B
| $69.4M | 1.24% | 2,000,000 +350,000 | +21% | +$12.1M |
|
17
Medtronic
MDT
$119B
| $64.1M | 1.15% | 516,000 -20,000 | -4% | -$2.48M |
|
18
Campbell Soup
CPB
$9.52B
| $59.8M | 1.07% | 1,312,000 +388,000 | +42% | +$17.7M |
|
|
BLUE
19
DELISTED
bluebird bio
BLUE
| $58.7M | 1.05% | 1,836,000 -128,000 | -7% | -$4.09M |
|
20
Vanda Pharmaceuticals
VNDA
$279M
| $58.4M | 1.05% | 2,714,000 -1,082,000 | -29% | -$23.3M |
|
21
Madrigal Pharmaceuticals
MDGL
$9.76B
| $57.7M | 1.03% | 592,000 +242,000 | +69% | +$23.6M |
|
22
Catalyst Pharmaceutical
CPRX
$2.52B
| $57.5M | 1.03% | 10,000,000 | – | – |
|
|
23
lululemon athletica
LULU
$24.2B
| $56.9M | 1.02% | 155,994 +122,621 | +367% | +$44.8M |
|
24
Uber
UBER
$196B
| $54.7M | 0.98% | 1,092,000 +732,000 | +203% | +$36.7M |
|
25
Energizer
ENR
$1.88B
| $54.7M | 0.98% | 1,272,000 +224,000 | +21% | +$9.63M |
|